UBS Group Cuts Sabra Healthcare REIT (NASDAQ:SBRA) Price Target to $21.00

Posted by Brian Himes on Jul 11th, 2026

Sabra Healthcare REIT (NASDAQ:SBRA – Free Report) had its target price cut by UBS Group from $22.00 to $21.00 in a research note released on Wednesday,Benzinga reports. They currently have a neutral rating on the real estate investment trust’s stock.

Several other equities research analysts have also commented on the company. Barclays initiated coverage on Sabra Healthcare REIT in a research report on Tuesday. They issued an “overweight” rating and a $21.00 price objective on the stock. Cantor Fitzgerald upped their price objective on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a report on Monday, May 11th. Truist Financial upgraded Sabra Healthcare REIT from a “hold” rating to a “buy” rating and set a $22.00 price objective on the stock in a report on Wednesday. Wall Street Zen raised shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research report on Sunday, June 28th. Finally, Weiss Ratings downgraded Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (b)” rating in a report on Thursday, June 4th. Five investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $21.45.

Read Our Latest Stock Report on SBRA

Sabra Healthcare REIT Stock Down 1.3%

Shares of NASDAQ SBRA opened at $19.62 on Wednesday. Sabra Healthcare REIT has a 12-month low of $17.17 and a 12-month high of $21.28. The stock’s fifty day simple moving average is $19.67 and its two-hundred day simple moving average is $19.70. The stock has a market capitalization of $4.95 billion, a PE ratio of 31.14, a price-to-earnings-growth ratio of 1.48 and a beta of 0.65. The company has a current ratio of 4.72, a quick ratio of 4.72 and a debt-to-equity ratio of 0.96.

Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last announced its earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share for the quarter, meeting the consensus estimate of $0.16. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The company had revenue of $211.74 million during the quarter, compared to the consensus estimate of $209.20 million. During the same period last year, the firm earned $0.37 earnings per share. Sabra Healthcare REIT’s revenue was up 20.9% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, analysts expect that Sabra Healthcare REIT will post 1.5 EPS for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, May 29th. Stockholders of record on Friday, May 15th were given a $0.30 dividend. The ex-dividend date of this dividend was Friday, May 15th. This represents a $1.20 annualized dividend and a dividend yield of 6.1%. Sabra Healthcare REIT’s dividend payout ratio is presently 190.48%.

Hedge Funds Weigh In On Sabra Healthcare REIT

A number of institutional investors have recently added to or reduced their stakes in the company. Rothschild Investment LLC boosted its stake in shares of Sabra Healthcare REIT by 164.6% during the 4th quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock valued at $27,000 after buying an additional 889 shares during the last quarter. Smartleaf Asset Management LLC boosted its stake in Sabra Healthcare REIT by 97.7% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock valued at $27,000 after acquiring an additional 714 shares during the period. Founders Capital Management bought a new position in Sabra Healthcare REIT during the 3rd quarter worth $28,000. Strengthening Families & Communities LLC bought a new position in shares of Sabra Healthcare REIT during the fourth quarter worth about $29,000. Finally, Versant Capital Management Inc increased its stake in shares of Sabra Healthcare REIT by 70.0% in the second quarter. Versant Capital Management Inc now owns 1,465 shares of the real estate investment trust’s stock valued at $29,000 after purchasing an additional 603 shares during the period. Institutional investors and hedge funds own 99.40% of the company’s stock.

About Sabra Healthcare REIT

(Get Free Report)

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.